Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 16,449 | 16,806 | 11,792 | 11,338 | 7,295 |
| Operating Income | -16,449 | -16,806 | -11,792 | -11,338 | -7,295 |
| Interest Expense | 0 | 0 | 0 | 0 | -1 |
| Other Income | 909 | 1,002 | 945 | 930 | 1,027 |
| Pre-tax Income | -15,540 | -15,804 | -10,847 | -10,408 | -6,267 |
| Net Income Continuous | -15,540 | -15,804 | -10,847 | -10,408 | -6,267 |
| Net Income | $-15,540 | $-15,804 | $-10,847 | $-10,408 | $-6,267 |
| EPS Basic Total Ops | -0.39 | -0.40 | -0.27 | -0.28 | 3.99 |
| EPS Basic Continuous Ops | -0.39 | -0.40 | -0.27 | -0.28 | 3.98 |
| EPS Diluted Total Ops | -0.39 | -0.40 | -0.27 | -0.28 | 3.99 |
| EPS Diluted Continuous Ops | -0.39 | -0.40 | -0.27 | -0.28 | 3.98 |
| EPS Diluted Before Non-Recurring Items | -0.38 | -0.40 | -0.27 | -0.28 | -0.18 |
| EBITDA(a) | $-16,449 | $-16,806 | $-11,792 | $-11,338 | $-7,295 |